Back to Search Start Over

Amygdala activity after subchronic escitalopram administration in healthy volunteers: A pharmaco-functional magnetic resonance imaging study.

Authors :
Lukow, Paulina B
Lowther, Millie
Pike, Alexandra C
Yamamori, Yumeya
Chavanne, Alice V
Gormley, Siobhan
Aylward, Jessica
McCloud, Tayla
Goble, Talya
Rodriguez-Sanchez, Julia
Tuominen, Ella W
Buehler, Sarah K
Kirk, Peter
Robinson, Oliver J
Source :
Journal of Psychopharmacology; Dec2024, Vol. 38 Issue 12, p1071-1082, 12p
Publication Year :
2024

Abstract

Background: Selective serotonin reuptake inhibitors (SSRIs) are used for the treatment of several conditions including anxiety disorders, but the basic neurobiology of serotonin function remains unclear. The amygdala and prefrontal cortex are strongly innervated by serotonergic projections and have been suggested to play an important role in anxiety expression. However, serotonergic function in behaviour and SSRI-mediated neurobiological changes remain incompletely understood. Aims: To investigate the neural correlates of subchronic antidepressant administration. Methods: We investigated whether the 2- to 3-week administration of a highly selective SSRI (escitalopram) would alter brain activation on a task robustly shown to recruit the bilateral amygdala and frontal cortices in a large healthy volunteer sample. Participants performed the task during a functional magnetic resonance imaging acquisition before (n = 96) and after subchronic escitalopram (n = 46, days of administration mean (SD) = 15.7 (2.70)) or placebo (n = 40 days of administration mean (SD) = 16.2 (2.90)) self-administration. Results: Compared to placebo, we found an elevation in right amygdala activation to the task after escitalopram administration without significant changes in mood. This effect was not seen in the left amygdala, the dorsomedial region of interest, the subgenual anterior cingulate cortex or the right fusiform area. There were no significant changes in connectivity between the dorsomedial cortex and amygdala or the subgenual anterior cingulate cortex after escitalopram administration. Conclusions: To date, this most highly powered study of subchronic SSRI administration indicates that, contrary to effects often seen in patients with anxiety disorders, subchronic SSRI treatment may increase amygdala activation in healthy controls. This finding highlights important gaps in our understanding of the functional role of serotonin. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
02698811
Volume :
38
Issue :
12
Database :
Complementary Index
Journal :
Journal of Psychopharmacology
Publication Type :
Academic Journal
Accession number :
180677349
Full Text :
https://doi.org/10.1177/02698811241286773